Daré Bioscience, Inc.: Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update
Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate - pivotal Phase 3 contra ...
manilatimes13d
Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update
Daré will host a conference call and live webcast today, November 14, 2024, at 4:30 p.m. Eastern Time to review financial ...
Mena FN14d
Daré Bioscience Reports Third Quarter 2024 Financial Results And Provides Company Update
In addition to the continued commercialization by our collaborator Organon of XACIATO TM (clindamycin phosphate) vaginal gel 2%, the first FDA-approved product to emerge from our portfolio and a ...
Medindia20d
How to Take Clindamycin and it's Dose
It comes as a capsule and liquid to take by mouth, with or without food. Granules should be taken with food.It also comes as a solution for injection to be administered by a healthcare provider ...